Artificial sweeteners: regulation in Brazil, technological implications in food production and health
DOI:
https://doi.org/10.46311/2318-0579.59.eUJ4280Keywords:
Aspartame, artificial sweetener, saccharin, sugar substitutesAbstract
Sweeteners provide a sweet taste to foods and are used to replace sucrose and reduce caloric value. Acesulfame potassium, aspartame, sodium cyclamate, saccharin, sucralose and neotame are the artificial sweeteners regulated in Brazil by the Brazilian Health Regulatory Agency (ANVISA). The consumption of these additives has become controversial due to recent scientific evidence questioning their safety and outcomes regarding weight loss, dysbiosis of the intestinal microbiota, insulin resistance, diabetes and cancer. Even today, little is known about the long-term consequences of their consumption. Therefore, this study aimed to carry out a review of artificial sweeteners regulated in Brazil, contextualizing their regulatory framework, the technological implications regarding their use and the effects on health. Considering the now controversial outcomes regarding the consumption of many artificial sweeteners, and the long period in which levels of acceptable daily intake have been in place, it is suggested their consumption should now not be encouraged, being restricted to population groups that have a risk-based physiological or metabolic need to replace sucrose. Also, for these cases, it would be important to differentiate between foods containing different sweeteners (or tabletop sweeteners), to alleviate possible chronic health effects. New studies with more robust and consistent methodologies are required to support the safety assessment reviews of each artificial sweetener.
Downloads
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Revista Uningá
This work is licensed under a Creative Commons Attribution 4.0 International License.
I declare/we declare that the text submitted here is original, of my own authorship and does not infringe any type of third party rights. The content is my/our sole responsibility. Possible research involving animals and/or human beings is in accordance with Resolution 196/96 of the National Health Council and its complements. I declare that I am/we are in possession of the written consent of patients and that the research and its procedures were timely and adequately approved by the Ethics Committee of the institution of origin. We further declare that all institutional affiliations and all sources of financial support for the work are duly informed. I certify that there is no commercial or associative interest that represents a conflict of interest related to the submitted work. If there is commercial interest, in addition to the technical and academic ones, in the publication of the article, the information will be reported during the text.
